DRRX Update, FDX Options

DURECT Corp. DRRX – Review

With one half session remaining before the midweek holiday hiatus, and the earnings calendar once again void of activity, we want to circle back to a recent mention of ours in DRRX. We placed the stock on our radar last month on the 12th, and in the roughly five weeks since, it had really begun to put up some solid performances.

Subsequent to its inclusion in our premarket report on 11/12, DRRX registered a low of 1.72, and yesterday the stock once again registered a new high of 3.00. That’s an overall increase of 74% The stock also closed just a few cents below its high of day, so we’ll continue to keep an eye on its activity.


FedEx Corp. FDX – Fresh Options Idea

FedEx recently reversed and bounced off of its lows, and now appears to be in position to begin filling a gap on the chart. In anticipation of this we are going to place a range of calls in the FDX chain on longer term watch.

We;re going to go out to the FDX 01/31 $157.50-160 Calls to continue to track through the holidays and into the new year.


Extended Watchlist:
EKSO, ZN, OGEN, PT, KOD, SLNO, VLRX, ITCI,

Blue Horseshoe Stocks: Stock Updates

Catalyst Pharma Inc. CPRX

We saw a very impressive new high for a stock that we’ve been tracking off of a bottom since February 8th. CPRX traded for as little as 2.36 that day, and has never looked back, spending most of the 7 weeks since then in a general uptrend that really kicked into high gear yesterday.

The stock ultimately reached 5.25 before closing just a penny below that point. That works out to an upswing of 122% in well under two months’ time.


Axsome Therapuetics, Inc. AXSM 

Speaking of stock runners, we called out AXSM for observation just last Thursday, and wanted to drop back in on it to comment regarding its performance thus far. From a low of 11.75 on Thursday morning, the stock has now reached as high as 16.38. That’s a relatively modest but still very respectable gain of 39% in a span of just three sessions.


Extended Watchlist:
SRNE, BPTH, BE, VLRX, ZUO, ATOS, BOXL, VTL, RWLK, ZDGE

Blue Horseshoe Stocks: RARX Review & More

Ra Pharmaceuticals. Inc. RARX

It was the morning of December 12th that we most recently highlighted RARX, and it is one stock that has weathered the ups and downs of the past few weeks quite well. In fact, subsequent to that report, we’ve observed a run from a low of 15.23, up as high as 22.15. That amounts to a run of 45% which is highly respectable for a $15+ stock over a short time span.

That high also represented a new 52-week high for the stock, which is especially impressive when you consider that most stocks out there are just now coming off of recently established annual lows. We’ll be highly interested to see if RARX can continue to push its upper limits.

For what it’s worth, our first-ever mention of RARX came last February, when it was trading at less than $6/share.


Petroleo Brasileiro SA (Petrobras) PBR

We’ve got a long history with PBR options that stretches back years, as you can see in our PBR Archive. Like a lot of other stocks we’re seeing, PBR is coming off of recent relative lows, and has gained a quick boost from the loosening pressure on the markets over the past week.

PBR has breached its 50-day moving average in the premarket, and we want to line up a pair of quick-strike options trading possibilities to correspond with this volatile activity. We’ll be watching the PBR Weekly $14 & 14.50 Calls.


Extended Watchlist:
ICON, SBS, MYSZ, NVCN, APDN, BTAI, VLRX, IMMR